(Q50865906)

English

Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.

scientific article published on 26 March 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction. (English)

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

mesenchymal stem cell

1 reference

based on heuristic

inferred from title

author name string

Liyan Zhao

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Xiaolin Liu

2

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Yuelin Zhang

3

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Xiaoting Liang

4

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Yue Ding

5

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Yan Xu

6

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Zhen Fang

7

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Fengxiang Zhang

8

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

language of work or name

0 references

publication date

26 March 2016

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Experimental Cell Research

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

344

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

1

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

30-39

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Left ventricular remodeling after myocardial infarction: pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Evidence for cardiomyocyte renewal in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Cardiac stem cell therapy and the promise of heart regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal stem cells and their potential as cardiac therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal stem cells for cardiac cell therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Rap1-mediated nuclear factor-kappaB (NF-κB) activity regulates the paracrine capacity of mesenchymal stem cells in heart repair following infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Interaction between mesenchymal stem cells and endothelial cells restores endothelial permeability via paracrine hepatocyte growth factor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal Stem Cells Pretreated with HGF and FGF4 Can Reduce Liver Fibrosis in Mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal stem cells overexpressing hepatocyte growth factor (HGF) inhibit collagen deposit and improve bladder function in rat model of bladder outlet obstruction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

HGF Gene Modification in Mesenchymal Stem Cells Reduces Radiation-Induced Intestinal Injury by Modulating Immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Derivation of Clinically Compliant MSCs from CD105+, CD24− Differentiated Human ESCs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Interruption of hepatocyte growth factor signaling augmented oridonin-induced death in human non-small cell lung cancer A549 cells via c-met-nuclear factor-κB-cyclooxygenase-2 and c-Met-Bcl-2-caspase-3 pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Met signaling in cardiomyocytes is required for normal cardiac function in adult mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Human umbilical cord blood mononuclear cell-conditioned media inhibits hypoxic-induced apoptosis in human coronary artery endothelial cells and cardiac myocytes by activation of the survival protein Akt.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Enhanced engraftment and repairing ability of human adipose-derived stem cells, conveyed by pharmacologically active microcarriers continuously releasing HGF and IGF-1, in healing myocardial infarction in rats.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Blockade of the Ras/MEK/ERK and Ras/PI3K/Akt pathways by statins reduces the expression of bFGF, HGF, and TGF-β as angiogenic factors in mouse osteosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy increased pro-angiogenic factors, reduced fibrosis and improved heart function in the infarcted rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Intra-myocardial injection of both growth factors and heart derived Sca-1+/CD31- cells attenuates post-MI LV remodeling more than does cell transplantation alone: neither intervention enhances functionally significant cardiomyocyte regeneration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2016.03.024

7 January 2021

Identifiers

10.1016/J.YEXCR.2016.03.024

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

1 reference

Europe PubMed Central

24 March 2018

http://europepmc.org/abstract/MED/27025401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50865906&oldid=1445905516"